Overview

The 2025 DIA Asia Meeting invites you to join an inspiring gathering of regulators, academia, clinicians, patient representatives, and industry leaders from across China, Korea, Japan, Singapore, Southeast Asia, and beyond. This year’s theme, Integrating Clinical Trials into Clinical Practice, highlights the essential role of collaboration and innovation in driving better patient outcomes and transforming healthcare in Asia.

Don’t miss this opportunity to shape the Future of Healthcare in Asia.

Join us to gain invaluable knowledge, expand your professional network and collaboration, and prepare for the challenges and opportunities that lie ahead.

View Flyer

Featured topics

- Digital Health to Revolutionize Patient Care: Discover how AI and machine learning are shaping drug development, clinical trial execution, and operational efficiency in healthcare.
- Unlocking the Power of Real-World Data (RWD): Learn strategies to address operational and functional challenges, ensuring fit-for-purpose data assets from electronic medical records (EMR), claims, patient registries, genomics data, and more.
- Advancing Precision Medicine: Discuss breakthroughs in targeted treatments for rare diseases and oncology, transforming care so patients receive the right treatment at the right time.
- Enhancing Regulatory Oversight and Compliance: Examine the balance between regulatory and ethical oversight and the practical applications of regulatory science in clinical practice.
- With deep dives into these pivotal topics, the conference will provide actionable insights into the latest trends in clinical research, AI, digital health and regulatory science, offering a platform to exchange best practices and drive healthcare transformation across the region.

Featured

Want to learn more about DIA Asia Meeting 2025? You've come to the right site!

Exhibits

Learn more

Exhibits

Learn more

Learning objectives

- Receive updates from senior regulators how healthcare products are regulated, what actions/ plans they have for regulating innovative products and clinical trials, and their collaborations with key stakeholders.
- Hear the dialogues between regulators, patient representatives and industries on Clinical Research and the Product Registration topics.
- Receive the information on hot regulatory topics, such as ICH guidelines, AI, and new technologies adopted in R&D.
- ASEAN Townhall: Hear deliberation about the topics discussed at this DIA Singapore from the ASEAN countries regulators.
- Network with regulators, patient representatives, clinical development, pharmacovigilance and regulatory affairs professionals from industries.

Program Committee

Jing Ping Yeo, PhD Global Head, Project Operations & Head, Transformation
George Clinical, Singapore
Yil-Seob Lee, MD, PhD Professor
CHA Bundang Medical Center , Korea, Republic of
Rie Matsui, RPh Senior Director, International Labeling APAC
Pfizer R&D Japan G.K., Japan
Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Senior Advisor
BeiGene (Beijing) Co., Ltd., China
Young Joo Park, PhD, MPH VP, Korea, Singapore, and Southeast Asia
DIA, Korea, Republic of
Joon-woo Bahn, MD, PhD Professor
Asan Medical Center, Department of Convergence Medicine,, Korea, Republic of
Endang Wahjuningtyas Hoyaranda President
Indonesian Association For the Study of Medicinals (IASMED), Indonesia
Ken Lee EVP
SYNEOS HEALTH SINGAPORE PTE LTD, Singapore
John CW Lim, MD, MSc Executive Director
Centre of Regulatory Excellence, Duke-NUS Medical School, Si, Singapore
Ling Su, PhD Research Fellow
Shenyang Pharmaceutical University, Yeehong Business School, China
Mitsuhiro Niimi, PhD Vice President & Managing Director, Japan
DIA, Japan
Shun Jin, MBA Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
Tina Sun Study & Site Operations Country Head, Development Coordinator (Taiwan)
Taiwan Clinical Research Association (TCRA), Taiwan
Tong-Yan Wang Senior Vice President & Managing Director, DIA China
DIA, China
Jack Wong Founder
ARPA (Asia Regulatory Professionals Association) , Singapore
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore